The FDA Just Opened Up Access to a Promising New Alzheimer's Drug

medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.to modestly reduce cognitive decline among patients in the early stages of the disease.​Leqembi was initially granted"accelerated approval" by the Food and Drug Administration in January, which meant it was not broadly covered by the government-run Medicare program for people aged 65 and older.

​"This confirmatory study verified that it is a safe and effective treatment for patients with Alzheimer's disease," senior FDA official Teresa Buracchio said in a statement. ​But people covered by Medicare will still need to meet 20 percent of the cost, or thousands of dollars, themselves.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA to grant full approval for Alzheimer's medication LecanemabIf the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
Source: abc15 - 🏆 263. / 63 Read more »

FDA to make a decision on whether to approve first Alzheimer’s drugThe FDA is set to decide whether it will fully approve the first Alzheimer’s drug to show it could slow the disease’s progression in certain patients. But the decision could also have other implications, including who would get access to it.
Source: wjxt4 - 🏆 246. / 63 Read more »